These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 27840955)

  • 1. miR-141 regulation of EIF4E expression affects docetaxel chemoresistance of non-small cell lung cancer.
    Wang D; Ma J; Ji X; Xu F; Wei Y
    Oncol Rep; 2017 Jan; 37(1):608-616. PubMed ID: 27840955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-141 confers docetaxel chemoresistance of breast cancer cells via regulation of EIF4E expression.
    Yao YS; Qiu WS; Yao RY; Zhang Q; Zhuang LK; Zhou F; Sun LB; Yue L
    Oncol Rep; 2015 May; 33(5):2504-12. PubMed ID: 25813250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer.
    Ceppi P; Mudduluru G; Kumarswamy R; Rapa I; Scagliotti GV; Papotti M; Allgayer H
    Mol Cancer Res; 2010 Sep; 8(9):1207-16. PubMed ID: 20696752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-451 induces epithelial-mesenchymal transition in docetaxel-resistant lung adenocarcinoma cells by targeting proto-oncogene c-Myc.
    Chen D; Huang J; Zhang K; Pan B; Chen J; De W; Wang R; Chen L
    Eur J Cancer; 2014 Nov; 50(17):3050-67. PubMed ID: 25310895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-27b reverses docetaxel resistance of non-small cell lung carcinoma cells via targeting epithelial growth factor receptor.
    Chen S; Wang Q; Zhou XM; Zhu JP; Li T; Huang M
    Mol Med Rep; 2016 Jul; 14(1):949-54. PubMed ID: 27221512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docetaxel inhibits the proliferation of non-small-cell lung cancer cells via upregulation of microRNA-7 expression.
    He X; Li C; Wu X; Yang G
    Int J Clin Exp Pathol; 2015; 8(8):9072-80. PubMed ID: 26464649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3.
    Feng B; Wang R; Song HZ; Chen LB
    Cancer; 2012 Jul; 118(13):3365-76. PubMed ID: 22139708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation of DKK3 modulates docetaxel chemoresistance in human nonsmall cell lung cancer cell.
    Tao L; Huang G; Chen Y; Chen L
    Cancer Biother Radiopharm; 2015 Mar; 30(2):100-6. PubMed ID: 25760729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
    Kastl L; Brown I; Schofield AC
    Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-138 regulates chemoresistance in human non-small cell lung cancer via epithelial mesenchymal transition.
    Jin Z; Guan L; Song Y; Xiang GM; Chen SX; Gao B
    Eur Rev Med Pharmacol Sci; 2016; 20(6):1080-6. PubMed ID: 27049260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-200b regulates autophagy associated with chemoresistance in human lung adenocarcinoma.
    Pan B; Feng B; Chen Y; Huang G; Wang R; Chen L; Song H
    Oncotarget; 2015 Oct; 6(32):32805-20. PubMed ID: 26416454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic miR-9 is a target of erlotinib in NSCLCs.
    Chen X; Zhu L; Ma Z; Sun G; Luo X; Li M; Zhai S; Li P; Wang X
    Sci Rep; 2015 Nov; 5():17031. PubMed ID: 26593208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taxane-Platin-Resistant Lung Cancers Co-develop Hypersensitivity to JumonjiC Demethylase Inhibitors.
    Dalvi MP; Wang L; Zhong R; Kollipara RK; Park H; Bayo J; Yenerall P; Zhou Y; Timmons BC; Rodriguez-Canales J; Behrens C; Mino B; Villalobos P; Parra ER; Suraokar M; Pataer A; Swisher SG; Kalhor N; Bhanu NV; Garcia BA; Heymach JV; Coombes K; Xie Y; Girard L; Gazdar AF; Kittler R; Wistuba II; Minna JD; Martinez ED
    Cell Rep; 2017 May; 19(8):1669-1684. PubMed ID: 28538184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
    Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
    J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1.
    Feng B; Wang R; Chen LB
    Cancer Lett; 2012 Apr; 317(2):184-91. PubMed ID: 22120675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-2 downregulation sensitizes nonsmall cell lung cancer cells to cisplatin, but not to docetaxel.
    Losert D; Pratscher B; Soutschek J; Geick A; Vornlocher HP; Müller M; Wacheck V
    Anticancer Drugs; 2007 Aug; 18(7):755-61. PubMed ID: 17581297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-650 was a prognostic factor in human lung adenocarcinoma and confers the docetaxel chemoresistance of lung adenocarcinoma cells via regulating Bcl-2/Bax expression.
    Huang JY; Cui SY; Chen YT; Song HZ; Huang GC; Feng B; Sun M; De W; Wang R; Chen LB
    PLoS One; 2013; 8(8):e72615. PubMed ID: 23991130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncoupling protein 2 downregulation by hypoxia through repression of peroxisome proliferator-activated receptor γ promotes chemoresistance of non-small cell lung cancer.
    Wang M; Li G; Yang Z; Wang L; Zhang L; Wang T; Zhang Y; Zhang S; Han Y; Jia L
    Oncotarget; 2017 Jan; 8(5):8083-8094. PubMed ID: 28042952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquisition of radioresistance in docetaxel-resistant human lung adenocarcinoma cells is linked with dysregulation of miR-451/c-Myc-survivin/rad-51 signaling.
    Wang R; Chen DQ; Huang JY; Zhang K; Feng B; Pan BZ; Chen J; De W; Chen LB
    Oncotarget; 2014 Aug; 5(15):6113-29. PubMed ID: 25026294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical relevance of the miR-197/CKS1B/STAT3-mediated PD-L1 network in chemoresistant non-small-cell lung cancer.
    Fujita Y; Yagishita S; Hagiwara K; Yoshioka Y; Kosaka N; Takeshita F; Fujiwara T; Tsuta K; Nokihara H; Tamura T; Asamura H; Kawaishi M; Kuwano K; Ochiya T
    Mol Ther; 2015 Apr; 23(4):717-27. PubMed ID: 25597412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.